172 related articles for article (PubMed ID: 34050700)
1. Functional analysis of LAT3 in prostate cancer: Its downstream target and relationship with androgen receptor.
Rii J; Sakamoto S; Sugiura M; Kanesaka M; Fujimoto A; Yamada Y; Maimaiti M; Ando K; Wakai K; Xu M; Imamura Y; Shindo N; Hirota T; Kaneda A; Kanai Y; Ikehara Y; Anzai N; Ichikawa T
Cancer Sci; 2021 Sep; 112(9):3871-3883. PubMed ID: 34050700
[TBL] [Abstract][Full Text] [Related]
2. Targeting amino acid transport in metastatic castration-resistant prostate cancer: effects on cell cycle, cell growth, and tumor development.
Wang Q; Tiffen J; Bailey CG; Lehman ML; Ritchie W; Fazli L; Metierre C; Feng YJ; Li E; Gleave M; Buchanan G; Nelson CC; Rasko JE; Holst J
J Natl Cancer Inst; 2013 Oct; 105(19):1463-73. PubMed ID: 24052624
[TBL] [Abstract][Full Text] [Related]
3. Androgen receptor and nutrient signaling pathways coordinate the demand for increased amino acid transport during prostate cancer progression.
Wang Q; Bailey CG; Ng C; Tiffen J; Thoeng A; Minhas V; Lehman ML; Hendy SC; Buchanan G; Nelson CC; Rasko JE; Holst J
Cancer Res; 2011 Dec; 71(24):7525-36. PubMed ID: 22007000
[TBL] [Abstract][Full Text] [Related]
4. EGF-activated PI3K/Akt signalling coordinates leucine uptake by regulating LAT3 expression in prostate cancer.
Zhang BK; Moran AM; Bailey CG; Rasko JEJ; Holst J; Wang Q
Cell Commun Signal; 2019 Jul; 17(1):83. PubMed ID: 31345230
[TBL] [Abstract][Full Text] [Related]
5. The small SLC43 family: facilitator system l amino acid transporters and the orphan EEG1.
Bodoy S; Fotiadis D; Stoeger C; Kanai Y; PalacĂn M
Mol Aspects Med; 2013; 34(2-3):638-45. PubMed ID: 23268354
[TBL] [Abstract][Full Text] [Related]
6. Monoterpene glycoside ESK246 from Pittosporum targets LAT3 amino acid transport and prostate cancer cell growth.
Wang Q; Grkovic T; Font J; Bonham S; Pouwer RH; Bailey CG; Moran AM; Ryan RM; Rasko JE; Jormakka M; Quinn RJ; Holst J
ACS Chem Biol; 2014 Jun; 9(6):1369-76. PubMed ID: 24762008
[TBL] [Abstract][Full Text] [Related]
7. Suppression of amino acid transporter LAT3 expression on proliferation of K562 cells.
Xu SM; Tang K; Meng L; Tang Y
J Huazhong Univ Sci Technolog Med Sci; 2013 Oct; 33(5):632-635. PubMed ID: 24142711
[TBL] [Abstract][Full Text] [Related]
8. Abhydrolase domain containing 2, an androgen target gene, promotes prostate cancer cell proliferation and migration.
Obinata D; Takada S; Takayama K; Urano T; Ito A; Ashikari D; Fujiwara K; Yamada Y; Murata T; Kumagai J; Fujimura T; Ikeda K; Horie-Inoue K; Homma Y; Takahashi S; Inoue S
Eur J Cancer; 2016 Apr; 57():39-49. PubMed ID: 26854828
[TBL] [Abstract][Full Text] [Related]
9. CA916798 affects growth and metastasis of androgen-dependent prostate cancer cells.
He J; Lan X; Duan HL; Luo H; Zhou XD
Eur Rev Med Pharmacol Sci; 2018 Jul; 22(14):4477-4487. PubMed ID: 30058677
[TBL] [Abstract][Full Text] [Related]
10. TGF-beta signaling and androgen receptor status determine apoptotic cross-talk in human prostate cancer cells.
Zhu ML; Partin JV; Bruckheimer EM; Strup SE; Kyprianou N
Prostate; 2008 Feb; 68(3):287-95. PubMed ID: 18163430
[TBL] [Abstract][Full Text] [Related]
11. Prostate Cancer Cells in Different Androgen Receptor Status Employ Different Leucine Transporters.
Otsuki H; Kimura T; Yamaga T; Kosaka T; Suehiro JI; Sakurai H
Prostate; 2017 Feb; 77(2):222-233. PubMed ID: 27696482
[TBL] [Abstract][Full Text] [Related]
12. 5alpha-androstane-3alpha,17beta-diol supports human prostate cancer cell survival and proliferation through androgen receptor-independent signaling pathways: implication of androgen-independent prostate cancer progression.
Yang Q; Titus MA; Fung KM; Lin HK
J Cell Biochem; 2008 Aug; 104(5):1612-24. PubMed ID: 18320593
[TBL] [Abstract][Full Text] [Related]
13. Up-Regulation of LAT1 during Antiandrogen Therapy Contributes to Progression in Prostate Cancer Cells.
Xu M; Sakamoto S; Matsushima J; Kimura T; Ueda T; Mizokami A; Kanai Y; Ichikawa T
J Urol; 2016 May; 195(5):1588-1597. PubMed ID: 26682754
[TBL] [Abstract][Full Text] [Related]
14. Estrogen induces androgen-repressed SOX4 expression to promote progression of prostate cancer cells.
Yang M; Wang J; Wang L; Shen C; Su B; Qi M; Hu J; Gao W; Tan W; Han B
Prostate; 2015 Sep; 75(13):1363-75. PubMed ID: 26015225
[TBL] [Abstract][Full Text] [Related]
15. SIRT7 depletion inhibits cell proliferation and androgen-induced autophagy by suppressing the AR signaling in prostate cancer.
Ding M; Jiang CY; Zhang Y; Zhao J; Han BM; Xia SJ
J Exp Clin Cancer Res; 2020 Feb; 39(1):28. PubMed ID: 32019578
[TBL] [Abstract][Full Text] [Related]
16. Corepressive function of nuclear receptor coactivator 2 in androgen receptor of prostate cancer cells treated with antiandrogen.
Takeda K; Hara N; Nishiyama T; Tasaki M; Ishizaki F; Tomita Y
BMC Cancer; 2016 May; 16():332. PubMed ID: 27225190
[TBL] [Abstract][Full Text] [Related]
17. RUNX1, an androgen- and EZH2-regulated gene, has differential roles in AR-dependent and -independent prostate cancer.
Takayama K; Suzuki T; Tsutsumi S; Fujimura T; Urano T; Takahashi S; Homma Y; Aburatani H; Inoue S
Oncotarget; 2015 Feb; 6(4):2263-76. PubMed ID: 25537508
[TBL] [Abstract][Full Text] [Related]
18. Silencing of lncRNA MALAT1 inhibits cell cycle progression via androgen receptor signaling in prostate cancer cells.
Dai X; Liu L; Liang Z; Guo K; Xu S; Wang H
Pathol Res Pract; 2019 Apr; 215(4):712-721. PubMed ID: 30642743
[TBL] [Abstract][Full Text] [Related]
19. Androgen receptor functions as a negative transcriptional regulator of DEPTOR, mTOR inhibitor.
Kanno Y; Zhao S; Yamashita N; Yanai K; Nemoto K; Inouye Y
J Toxicol Sci; 2015 Dec; 40(6):753-8. PubMed ID: 26558456
[TBL] [Abstract][Full Text] [Related]
20. High level of androgen receptor is associated with aggressive clinicopathologic features and decreased biochemical recurrence-free survival in prostate: cancer patients treated with radical prostatectomy.
Li R; Wheeler T; Dai H; Frolov A; Thompson T; Ayala G
Am J Surg Pathol; 2004 Jul; 28(7):928-34. PubMed ID: 15223964
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]